Equity

Redeemable NCI

McKesson Redeemable NCI increased by 17.6% to $943.00M in Q1 2026 compared to the prior quarter. Over 3 years (FY 2021 to FY 2026), Redeemable NCI shows a downward trend with a -9.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ4 2015
Last reportedQ4 2026May 8, 2026

How to read this metric

An increase indicates higher potential future cash obligations to minority partners, which may impact liquidity and capital allocation flexibility.

Detailed definition

This represents equity interests in subsidiaries held by third parties that include redemption features, such as a manda...

Peer comparison

Often found in companies with complex joint venture structures or partially owned infrastructure projects; peers report this outside of permanent equity.

Metric ID: redeemable_noncontrolling_interests

Historical Data

9 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Value$7.00M$0.00$0.00$0.00$0.00$725.00M$777.00M$802.00M$943.00M
QoQ Change-100.0%+7.2%+3.2%+17.6%
Range$0.00$943.00M
CAGR>999%
Current Streak3+ quarters growth

Redeemable NCI at Other Companies

Frequently Asked Questions

What is McKesson's redeemable nci?
McKesson (MCK) reported redeemable nci of $943.00M in Q1 2026.
What is the long-term trend for McKesson's redeemable nci?
Over 3 years (2021 to 2026), McKesson's redeemable nci has grown at a -9.5% compound annual growth rate (CAGR), from $1.27B to $943.00M.
What does redeemable nci mean?
Ownership stakes held by others in a subsidiary that the company may be required to buy back in the future.